The company develops devices for minimally invasive spine surgery, and aims to take advantage of the current open capacity to “round out” its portfolio.
“Our demand allows us to keep our partnerships strong and people in our specialized industry working,” CEO Robert Pace said in an April 2 statement. “We are confident that these hard times will soon subside and want to be prepared for the inevitable backlog of critical surgical procedures.”
Mr. Pace co-founded Osseus in 2012, and was appointed CEO of the company in January.
More articles on devices:
Medical freeze placed on NuVasive spinal rods in UK, Ireland
Michigan Head and Spine Institute surgeons take 45% pay cut during COVID-19
Nonsurgical procedures, mediocre care & COVID-19: 3 spine surgeons on the biggest threat to their practice
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.